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Inflammatory bowel disease (IBD) is a group of idiopathic chronic relapsing inflammatory 
conditions of the gastrointestinal tract. The precise etiology of IBD is unknown, 
although it is clearly multifactorial resulting from interplay of genetic, environmental 
and immunological factors. Epidemiological studies show that the incidence of IBD 
and other autoimmune disorders is low in the developing countries and more in the 
developed countries. Evidence suggests that therapeutic administration of helminth 
can reduce the symptoms of IBD in both animal models and man. However, one study 
show the rat tapeworm Hymenolepis diminuta infection results in significant exacerbation 
of oxazolone induced colitis in mice (Hunter et al., 2007). The mechanisms by 
which helminths interact with the gut immune system in IBD-susceptible hosts, particularly 
their effect on the onset and progression of colitis are poorly understood. To 
address this we have investigated the interaction between Trichuris muris and the 
mdr1a (-/-) mouse model, which lacks the epithelial barrier protein, p-glycoprotein and 
slowly develops a spontaneous colitis in the presence of a normal gut flora. 
PURPOSE OF THE STUDY: Our aim was to investigate (i) whether mdr1a gene deletion, 
which makes the host susceptible to colitis, alters host susceptibility to T.muris infection 
and (ii) the effects of T. muris infection on the development of colitis in mdr1a-/- 
mice. 
SUMMARIZED DESCRIPTION OF THE PROJECT: Pre-colitic mdr1a-/- or FVB congenic 
control mice were infected with approximately 175 embryonated T. muris ova at 5-9 
weeks of age. Worm counts, immunological responses and gut histology were analyzed 
on day 19 post infection. 
RESULTSANDCONCLUSIONS: The mdr1a -/- mice were unable to expel T.muris and had 
a higher worm burden at day 19 after infection compared to controls. This was associated 
with increased Th1 and Th2 cytokines, particularly IFN-gamma in the draining 
lymph nodes. Interestingly, there was also evidence that T. muris infection may accelerate 
the development of gut inflammation in the mdr1a-/- mice as judged by increased 
mucosal infiltration by CD4_,CD8_ and F4/80_ cells and other histological 
changes. However, the naı¨ve mdr1a-/- mice and infected controls of the similar age 
failed to show any signs of gut inflammation. This study shows that infection with 
Trichuris may worsen colitis in the precolitic mdr1a-/- model. Thus, worsening of inflammation 
in infected knock out mice could be a complex interaction between the 
translocated bacterial products (due to absence of P-glycoprotein molecule) and immunomodulatory 
molecules of worm. Thus, this study highlights that a better understanding 
of the complex relationship between gut parasites and IBD-susceptible hosts 
is required. 
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